TISSUE REGENIX GROUP PLC
A medical technology company developing biological products for tissue regeneration.
TRX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BNTXR104
- LEI:
- 213800PNOD5UHQUFJI36
- Country:
- United Kingdom
- Address:
- Unit 3, Phoenix Court Lotherton Way, LS25 2GY Leeds
- Website:
- https://www.tissueregenix.com/
- Sector:
- Manufacturing
Description
Tissue Regenix Group PLC is a medical technology company specializing in regenerative medicine. The company develops and commercializes biological products designed to repair and regenerate human tissue. It employs proprietary decellularization platform technologies to process human and animal tissues, creating acellular scaffolds. When implanted, these scaffolds support the patient's own cells in repopulating and regenerating the damaged area. The company's portfolio serves three main clinical areas: biosurgery for complex wound care, orthopaedics for sports medicine and bone graft substitutes, and dental applications for tissue and bone repair. Key products include DermaPure®, OrthoPure® XT, and the Matrix® line of bone graft substitutes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-22 17:20 |
Result of General Meeting and Cancellation
|
English | HTML • 23.9 KB | ||
| 2025-12-08 08:35 |
Update re. proposed cancellation of shares
|
English | HTML • 9.1 KB | ||
| 2025-12-04 15:55 |
Proposed £17.5m CLN raise, cancellation of Trading
|
English | HTML • 164.1 KB | ||
| 2025-12-01 08:25 |
Further re. financial update and funding plans
|
English | HTML • 8.7 KB | ||
| 2025-11-07 08:20 |
Financial update and funding plans
|
English | HTML • 9.4 KB | ||
| 2025-10-22 16:29 |
Statement re. Suspension
|
English | HTML • 12.3 KB | ||
| 2025-10-17 08:00 |
CFO joins Board
|
English | HTML • 11.2 KB | ||
| 2025-10-16 08:00 |
Update re. FY24 & H125 restatement & Board Changes
|
English | HTML • 16.2 KB | ||
| 2025-10-09 08:00 |
Holding(s) in Company
|
English | HTML • 52.9 KB | ||
| 2025-10-06 16:29 |
Holding(s) in Company
|
English | HTML • 52.9 KB | ||
| 2025-10-03 16:01 |
Holding(s) in Company
|
English | HTML • 53.0 KB | ||
| 2025-10-02 17:43 |
Holding(s) in Company
|
English | HTML • 24.7 KB | ||
| 2025-10-01 18:35 |
Holding(s) in Company
|
English | HTML • 51.5 KB | ||
| 2025-09-30 08:00 |
Half-year Report
|
English | HTML • 326.4 KB | ||
| 2025-09-17 08:00 |
Notice of Results
|
English | HTML • 11.5 KB |
Automate Your Workflow. Get a real-time feed of all TISSUE REGENIX GROUP PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TISSUE REGENIX GROUP PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TISSUE REGENIX GROUP PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
